Cyclo Therapeutics Inc (CTDH):企業の財務・戦略的SWOT分析

◆英語タイトル:Cyclo Therapeutics Inc (CTDH) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH207630FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥81,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥121,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cyclo Therapeutics Inc (Cyclo Therapeutics), formerly CTD Holdings Inc, is a biotechnology company that develops and manufactures cyclodextrin-based drugs. It is investigating Trappsol Cyclo, an orphan drug against Niemann-Pick disease type C and Alzheimer’s disease. The company also develops antibiotics, antiulcerants, throat disinfectants, vasodilators, antifungal drugs and other medications to treat chronic arterial occlusive disease, Buerger’s disease; control hypo-tension during surgery; and induction of labor. It serves diagnostics, industrial chemical industries, pharmaceutical and chemical supply distributors. Cyclo Therapeutics is headquartered in Alachua, Florida, the US.

Cyclo Therapeutics Inc Key Recent Developments

Mar 25,2021: Cyclo Therapeutics Meets Primary Efficacy Endpoint in Phase 1/2 Trial from Intravenous Trappsol® Cyclo™ in Rare Disease Niemann-Pick Type C1 (NPC1)
Mar 15,2021: Cyclo Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
Mar 10,2021: Cyclo Therapeutics Appoints Russ Belden as Acting Chief Commercial Officer
Mar 01,2021: Cyclo Therapeutics Appoints Gerald F. Cox, MD, PhD as Acting Chief Medical Officer

This comprehensive SWOT profile of Cyclo Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cyclo Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Cyclo Therapeutics Inc – Key Information
Cyclo Therapeutics Inc – Overview
Cyclo Therapeutics Inc – Key Employees
Cyclo Therapeutics Inc – Key Employee Biographies
Cyclo Therapeutics Inc – Key Operational Heads
Cyclo Therapeutics Inc – Major Products and Services
Cyclo Therapeutics Inc – History
Cyclo Therapeutics Inc – Company Statement
Cyclo Therapeutics Inc – Locations And Subsidiaries
Cyclo Therapeutics Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Cyclo Therapeutics Inc – Business Description
Cyclo Therapeutics Inc – Corporate Strategy
Cyclo Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Cyclo Therapeutics Inc – Strengths
Cyclo Therapeutics Inc – Weaknesses
Cyclo Therapeutics Inc – Opportunities
Cyclo Therapeutics Inc – Threats
Cyclo Therapeutics Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Cyclo Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Cyclo Therapeutics Inc, Key Information
Cyclo Therapeutics Inc, Key Ratios
Cyclo Therapeutics Inc, Share Data
Cyclo Therapeutics Inc, Major Products and Services
Cyclo Therapeutics Inc, History
Cyclo Therapeutics Inc, Key Employees
Cyclo Therapeutics Inc, Key Employee Biographies
Cyclo Therapeutics Inc, Key Operational Heads
Cyclo Therapeutics Inc, Other Locations
Cyclo Therapeutics Inc, Subsidiaries
Cyclo Therapeutics Inc, Key Competitors
Cyclo Therapeutics Inc, SWOT Analysis
Cyclo Therapeutics Inc, Ratios based on current share price
Cyclo Therapeutics Inc, Annual Ratios
Cyclo Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Cyclo Therapeutics Inc (CTDH):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pacific Edge Ltd (PEB):製品パイプライン分析
    Summary Pacific Edge Ltd (PEB) is a diagnostics company that discovers, develops and commercializes diagnostic tests for the early detection and monitoring of cancer. The company provides lead product such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It is develo …
  • Knight Therapeutics Inc (GUD):製薬・医療:M&Aディール及び事業提携情報
    Summary Knight Therapeutics Inc (Knight Therapeutics) is a specialty pharmaceutical company focused on acquisition, licensing, marketing and distribution of prescription, consumer health products and medical devices. Its consumer health products are used in the treatment of metabolic diseases, derma …
  • Asarco LLC:企業の戦略・SWOT・財務情報
    Asarco LLC - Strategy, SWOT and Corporate Finance Report Summary Asarco LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Indago Energy Ltd (INK):石油・ガス:M&Aディール及び事業提携情報
    Summary Indago Energy Ltd (Indago), formerly Pryme Energy Ltd is a provider of specialist oil and gas production chemicals. The company offers acquisition, up-gradation, exploration and production services to onshore oil and natural gas. It holds interests in the Newkirk project located in Kay Count …
  • Dimension Data Holdings Plc:企業の戦略的SWOT分析
    Dimension Data Holdings Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • OUTsurance Holdings Limited:企業の戦略・SWOT・財務情報
    OUTsurance Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary OUTsurance Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Tupperware Brands Corporation:企業の戦略・SWOT・財務分析
    Tupperware Brands Corporation - Strategy, SWOT and Corporate Finance Report Summary Tupperware Brands Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Total E&P Canada Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Total E&P Canada Ltd (Total E&P Canada), a subsidiary of Total S.A. is an oil and gas company that offers exploration and production of oil and gas properties. The company has assets in Alberta’s Athabasca Oil Sands region, which include Surmont, Northern Lights, Fort Hills and Joslyn North …
  • Shantui Construction Machinery Co Ltd:企業の戦略・SWOT・財務情報
    Shantui Construction Machinery Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Shantui Construction Machinery Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Vivus, Inc.:企業の戦略・SWOT・財務分析
    Vivus, Inc. - Strategy, SWOT and Corporate Finance Report Summary Vivus, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Development Center for Biotechnology-製薬・医療分野:企業M&A・提携分析
    Summary Development Center for Biotechnology (DCB) is a non-profit organization that provides support to biotechnology and pharmaceutical companies. The organization develops biotech industry through its cooperation and industrialization, key technologies, infrastructure building, research and devel …
  • Alitair Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Alitair Pharmaceuticals Inc (Alitair) is a pharmaceutical company that provides orphan drugs and medicine products. The company provides orphan drug products and RX and OTC cough and cold products. It offers orphan drug products such as ALT and oral drugs that are widely used to treat variou …
  • Adama Ltd (000553):企業の財務・戦略的SWOT分析
    Adama Ltd (000553) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • JSC Inter RAO:企業のM&A・事業提携・投資動向
    JSC Inter RAO - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's JSC Inter RAO Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Phenex Pharmaceuticals AG-製薬・医療分野:企業M&A・提携分析
    Summary Phenex Pharmaceuticals AG (Phenex) is a drug discovery and development company that offers nuclear receptors for the development of novel therapies. The company offer services which include contract screening services, NR selectivity screening and SNuRM profiling to pharmaceutical, biotechno …
  • Burgan Bank Sak
    Burgan Bank Sak - Strategy, SWOT and Corporate Finance Report Summary Burgan Bank Sak - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Sygnity SA (SGN):企業の財務・戦略的SWOT分析
    Sygnity SA (SGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • SugarBud Craft Growers Corp (RRL):企業の財務・戦略的SWOT分析
    Summary SugarBud Craft Growers Corp, (SugarBud) formerly New Range Resources Ltd is an oil and gas company that offers oil and gas exploration and development services. The company acquires, explores, operates, manages, produces, and develops crude oil and natural gas in Alberta and Saskatchewan. It …
  • Bow Energy Pty Ltd:企業の戦略的SWOT分析
    Bow Energy Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Rockwell Collins Inc:戦略・SWOT・企業財務分析
    Rockwell Collins Inc - Strategy, SWOT and Corporate Finance Report Summary Rockwell Collins Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆